WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1891-01-01

Employees: 10K

Market Cap: -

Website: http://www.medschool.wustl.edu

Clinical Trials

Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury

Phase 2

Completed

Conditions: Hemorrhage
Shock
Wounds and Injuries

Interventions: Other: Placebo
Drug: Tranexamic Acid

First Posted Date: 2015-08-31

Last Posted Date: 2021-08-31

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 150

Registration Number: NCT02535949

Locations: 🇺🇸
Barnes Jewish Hospital, Saint Louis, Missouri, United States

Supporting Decisions About Health Insurance to Improve Care for the Uninsured

Not Applicable

Completed

Conditions: Health Services Accessibility
Informed Decision Making
Health Insurance
Health Literacy

Interventions: Behavioral: Decision Aid (DA)

First Posted Date: 2015-08-13

Last Posted Date: 2018-02-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 328

Registration Number: NCT02522624

Locations: 🇺🇸
The Washington University in St. Louis School of Medicine, Saint Louis, Missouri, United States

Trendelenberg Versus Left Lateral Position for Colonoscopy

Completed

Conditions: Colonic Diseases

First Posted Date: 2015-08-11

Last Posted Date: 2016-11-02

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 150

Registration Number: NCT02519686

Locations: 🇺🇸
Washington University in St Louis School of Medicine, St Louis, Missouri, United States

Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma

Phase 1

Terminated

Conditions: Astrocytoma, Grade IV
Glioblastoma Multiforme

Interventions: Biological: Personalized peptide vaccine
Drug: Poly-ICLC
Drug: Temozolomide

First Posted Date: 2015-07-29

Last Posted Date: 2017-11-17

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 1

Registration Number: NCT02510950

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis (Volunteer - BioD and Safety Study)

Early Phase 1

Completed

Conditions: Atherosclerosis

Interventions: Drug: Cu[64]-25%CANF-Comb

First Posted Date: 2015-07-15

Last Posted Date: 2016-04-28

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 8

Registration Number: NCT02498379

Locations: 🇺🇸
Washington University in St.Louis, St.Louis, Missouri, United States

Vaginal Cleansing Before Cesarean Delivery to Reduce Infection

Not Applicable

Completed

Conditions: Complications; Cesarean Section

Interventions: Procedure: Vaginal Cleansing
Procedure: Abdominal Cleansing

First Posted Date: 2015-07-13

Last Posted Date: 2021-08-06

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 608

Registration Number: NCT02495753

Locations: 🇺🇸
Barnes Jewish Hospital, Saint Louis, Missouri, United States

Afatinib Genomic Landscape

Terminated

Conditions: Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Non-small Lung Cancer

First Posted Date: 2015-07-08

Last Posted Date: 2018-03-05

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 6

Registration Number: NCT02491775

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Evaluating Strategies to Present Colon Cancer Screening Information

Not Applicable

Completed

Conditions: Colonic Neoplasms
Gastrointestinal Neoplasms
Colonic Diseases
Colorectal Neoplasms

Interventions: Behavioral: Education information
Behavioral: Health communication intervention

First Posted Date: 2015-06-30

Last Posted Date: 2018-11-15

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 486

Registration Number: NCT02485561

Locations: 🇺🇸
Washington University website HeathStudy.wustl.edu, Saint Louis, Missouri, United States

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

Phase 2

Recruiting

Conditions: Breast Cancer
Cancer of Breast
Breast Neoplasms
Cancer of the Breast

Interventions: Behavioral: FACT-B
Drug: Goserelin
Drug: Anastrozole
Drug: Exemestane
Drug: Fulvestrant
Drug: Tamoxifen
Other: Archived tissue collection

First Posted Date: 2015-06-19

Last Posted Date: 2024-07-29

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 50

Registration Number: NCT02476786

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Fluid Balance in the ICU - Interventions to Minimize Fluids in Patients With Septic Shock

Not Applicable

Completed

Conditions: Hypotension
Septic Shock
Fluid Therapy

Interventions: Other: Fluid minimization protocol
Device: Ultrasound

First Posted Date: 2015-06-16

Last Posted Date: 2024-07-24

Lead Sponsor: Washington University School of Medicine

Target Recruit Count: 82

Registration Number: NCT02473718

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy